ArticleFrontiers in neuroinformatics2023
oFVSD: a Python package of optimized forward variable selection decoder for high-dimensional neuroimaging data.
Article in Frontiers in neuroinformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Association between atherogenic index of plasma and hypertension in children and adolescents based on LightGBM prediction model.Scientific reports · 2026Article
- Machine Learning Models for Predicting Antipsychotic Effectiveness and Separate Cost-Effectiveness Analysis in Hospitalized Schizophrenia Patients.Neuropsychiatric disease and treatment · 2026Article
- Online machine learning model for predicting delirium risk in elderly patients with chronic kidney disease: development and preliminary validation.European journal of medical research · 2025Article
- I-SVVS: integrative stochastic variational variable selection to explore joint patterns of multi-omics microbiome data.Briefings in bioinformatics · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The complexity and high dimensionality of neuroimaging data pose problems for decoding information with machine learning (ML) models because the number of features is often much larger than the number of observations. Feature selection is one of the crucial steps for determining meaningful target features in decoding; however, optimizing the feature selection from such high-dimensional neuroimaging data has been challenging using conventional ML models. Here, we introduce an efficient and high-performance decoding package incorporating a forward variable selection (FVS) algorithm and hyper-parameter optimization that automatically identifies the best feature pairs for both classification and regression models, where a total of 18 ML models are implemented by default. First, the FVS algorithm evaluates the goodness-of-fit across different models using the k-fold cross-validation step that identifies the best subset of features based on a predefined criterion for each model. Next, the hyperparameters of each ML model are optimized at each forward iteration. Final outputs highlight an optimized number of selected features (brain regions of interest) for each model with its accuracy. Furthermore, the toolbox can be executed in a parallel environment for efficient computation on a typical personal computer. With the optimized forward variable selection decoder (oFVSD) pipeline, we verified the effectiveness of decoding sex classification and age range regression on 1,113 structural magnetic resonance imaging (MRI) datasets. Compared to ML models without the FVS algorithm and with the Boruta algorithm as a variable selection counterpart, we demonstrate that the oFVSD significantly outperformed across all of the ML models over the counterpart models without FVS (approximately 0.20 increase in correlation coefficient,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.